Splenic hematopoiesis is a major feature in the course of myelofibrosis (MF). In fact, the spleen of patients with MF contains malignant hematopoietic stem cells retaining a complete differentiation program, suggesting both a pivotal role of the spleen in maintaining the disease and a tight regulation of hematopoiesis by the splenic microenvironment, in particular by mesenchymal stromal cells (MSCs). Little is known about splenic MSCs (Sp-MSCs), both in normal and in pathological context.
fore, very likely that a hematopoietic microenvironment exists in the MF spleen, where MSCs may play a role in the regulation of hematopoiesis, as it occurs in the BM. 4 In particular, it has been shown that osteoblastic cells 5 and SDF-11/nestin1 reticular adventitial and CXCL12 abundant reticular (CAR) cells 2, 6 are crucial for the regulation of HSPC lodgment, self-renewal, and function. More recently, it has become evident that sympathetic signals from the nervous system activated by circadian rhythms or stress conditions, control both bone turnover and HSPC migration and development by acting on nestinexpressing MSCs. 7, 8 We and others have previously reported that MSCs from the BM of patients with MF harbor genetics abnormalities and display an altered functional activity, suggesting that a primary MSC defect may either lead to or favor the pathogenesis of MF, 9-11 not differently from those derived from patients with multiple myeloma, 12 acute leukemia, 13 or myelodysplastic syndrome. 14 In this work, we describe the isolation, and the phenotypic, functional and genetic characterization of spleen-derived MSCs (Sp-MSCs)
of patients with MF, and compare them with their normal counterpart obtained from healthy subjects (HS) undergoing post-traumatic splenectomy.
| M E TH ODS

| Patients and donors
Twenty-five patients with MF and 13 HS were enrolled in the study, that was approved by the Institutional Review Board of IRCCS Policlinico San Matteo Foundation, Pavia. Patients with MF underwent splenectomy either because of anemia or symptomatic splenomegaly, or both; HS were splenectomized following traumatic lesion of the spleen.
Normal CD341 cells were obtained from mobilized peripheral blood.
All participants signed an informed consent for the inclusion in the study, which was conducted according to the rules and principles of the Helsinki Declaration.
| Isolation of MSCs from the spleen
Small (1-2 cm per side) cubic fragments of the spleen were obtained immediately after splenectomy and mononuclear cells (MNCs) isolated as described. 15 Cultures for the isolation and expansion of Sp-MSCs were set up and performed according to previously published standard methods used in our lab for expansion of BM-derived MSCs. 16 
| Sp-MSCs characterization
Clonogenic efficiency, immunophenotype, proliferative capacity (defined as cumulative Population Doubling, cPD), and differentiation capacity were evaluated as described. 16 
| Short term culture of megakaryocytes
To assess the ability of Sp-MSCs to sustain megakaryopiesis, Sp-MSCs were plated at a concentration of 2 3 10 4 MSCs/well in the lower chamber of 24-transwell plates (Corning, New York). 7 3 10 4 umbilical CB-derived CD34 1 cells were seeded in the upper chamber and cultured for 13 days in presence of recombinant human thrombopoietin, as described. 18, 19 At the end of the culture, the cells in the upper well were collected and stained with anti-human CD41-FITC and antihuman CD33-PE antibodies and analyzed by flow cytometry as described above. Mk diameters were measured using ImageJ software (National Institute of Health, USA), whereas ploidy was assessed by staining with propidium iodide followed by flow cytometry analysis, as described. 19 Experiments were performed in triplicates with Sp-MSCs from 5 MF patients and 3 HS.
| Nucleic acid extraction
DNA was isolated using QIAmp DNA Blood Mini Kit (Qiagen). Total RNA was extracted by the miRNeasy Mini Kit (Qiagen)and DNA purified with the RNase-free DNase Set (Qiagen). cDNA synthesis was performed using the iScript Kit (Bio-Rad) and analysed using the qPCR methods to test (i) RNA integrity, (ii) genomic DNA contamination, and (iii) presence of PCR inhibitors.
| RT-qPCR gene expression analysis
Predesigned PrimePCR SYBR Green assays were purchased from BioRad. Quantification of transcripts was performed in 20 mcl reaction mix with 1X SsoAdvanced Universal SYBR Green SuperMix (Bio-Rad).
Primers pairs were lyophilized in the wells of the PCR plates. PCR conditions were: 95C for 30 sec followed by 40 cycles at 95C for 5 sec and at 58C for 5 sec. Melting curves were generated after amplification in the range 65-95C with increments of 0.2C every 10 seconds. For each experiment, 4 mcl of cDNA, corresponding to 10 ng of total RNA, were used. The PCR data were collected using CFX96 RealTime System (Bio-Rad). Each sample was tested in triplicate. Calculation of normalized relative expression levels was done using the DD Cq method.
Normalization was performed using the 2 most stable reference genes (TBP and YWHAZ) selected using all the samples included in the study.
All analysis were performed with GenEx (version 6.1, MultiD).
2.8 | Western blot of FN1, MMP2, TPO, TGF-beta1, and SDF1
The same amount of proteins for each sample (MF patients n 5 3 and HS n 5 3) was separated by electrophoresis on 8%-10% sodium 
| Genetics
The JAK2V617F mutation was detected by an allele specific-qPCR, as reported. 20 MPL mutations were assessed by sequencing, 21 
| RE S U L TS
| Patients
Demographic and clinical characteristics of patients and HS are reported in Supporting Information Table S1 . Most of patients were males, with a median age higher, but not statistically different, than that of HS. Sixty-nine percent of patients had a primary MF; 20 patients harbored a JAK2V617F mutation in their granulocytes, whereas 2 and 3 had either CALR or MPL mutations, respectively.
| Phenotypical and functional characterization
Sp-MSCs were isolated and expanded in 12/25 (48%) patients and in 6/ 13 (46%) HS, and met the criteria for MSC definition 22 ( Figure 2C and Supporting Information Figure S1 ). Expression of Nestin RNA of patients was found to be similar to that of HS, at variance with the protein expression that was significantly lower in patients' MSC than in HS. An increased expression, which however, did not reach statistical significance, was observed for genes endowed with pro-angiogeneic activity (VEGFA, VEGFB, VEGFC and ANGPT1) as well as with the interaction between osteoclast and extracellular matrix (SPP1).
| Genetics of Sp-MSCs
Sp-MSCs at P2/P3 were tested for the presence of the JAK-2, CALR, and MPL mutations that were detected in the granulocytes of patients.
None of these mutations was found in the patients Sp-MSCs. Molecular karyotyping was performed by means of array-CGH in Sp-MSCs at Classical karyotyping showed a 46,XX,t(5;17)(q14;q12) in 1/18 metaphases of patient no. 17 (Table 1) , whereas a normal karyotype was observed in patients no. 7 and 10 and in 2/2 HS-derived MSCs. Taking into account both array CGH and karyotyping results, genetic abnormalities were found in 3/10 patients (33%) and never in Sp-MSCs from HS (n 5 5). Genetic aberrations observed in MSCs were not detectable in the hematopoietic compartment of the correspondent patients.
| D I SCUSSION
In MF hematopoiesis takes place not only in the BM but also in the spleen, where it is a major determinant of the splenomegaly that invariably characterizes the course of the disease, and is likely to be regulated by an organized microenvironment which might substantially resemble the hematopoietic niche that has been described in the BM. In fact, metalloproteases are considered, together with the CXCR4/ SDF-1 axis, among the main regulators of hematopoietic progenitor cell release from the BM niche into the bloodstream. 26 In particular, an increased MMP2 expression could be responsible of the cleavage of the N-terminus of SDF-1, resulting in an inactivated form of the protein. 27 As a matter of fact, increased levels of truncated SDF-1 have been described in patients with myelofibrosis. 28 We did not detect any expression of truncated SDF-1 at Western Blot ( Figure 1C ): however, it is likely that MMP2 cleavage activity is exerted on SDF-1 in the microenvironment outside the cell or in the bloodstream. 29 We also examined the level of expression of genes involved in the determination of biological or phenotypical features of MF such as altered megakaryocytopoiesis, neoangiogenesis, and fibrosis ( Figure   FIG 
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